Form EFFECT Atara Biotherapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 25, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lincoln Financial Announces Reinsurance Transaction with Talcott
- Anfield Energy Announces Pricing of US$6.0 million Underwritten Public Offering of Common Shares
- Mojo® Energy Pouches Expands Portfolio with the Launch of 100mg Caffeine Pouches and Four New Flavors
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
